Search research articles
Contact Us
Filters
Showing results (131-140 of 218) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study
Eric Van Cutsem, Sabine Tejpar, Dirk Vanbeckevoort, et al.
Anti-Cancer Drugs
|
July 9, 2020
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study
Christoph Schulz, Volker Heinemann, Kathrin Heinrich, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 3, 2014
Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial
Thomas Thomaidis, Annett Maderer, Andrea Formentini, et al.
World Journal of Gastroenterology
|
July 31, 2007
Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy?
Daniel Drescher, Markus Moehler, Ines Gockel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 16, 2012
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)
Salah-Eddin Al-Batran, Claudia Pauligk, Nils Homann, et al.
The Lancet. Oncology
|
April 19, 2013
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Florian Lordick, Yoon-Koo Kang, Hyun-Cheol Chung, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 11, 2018
PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression
Bastian Dörsam, Nina Seiwert, Sebastian Foersch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 4, 2016
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives
Markus Moehler, Maike Delic, Katrin Goepfert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2025
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis
Giacomo Bregni, Bryan Leurquin, Peggy Giasafaki, et al.
International Journal of Cancer
|
October 15, 2013
High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer
Naohide Oue, Katsuhiro Anami, Aaron J Schetter, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 218) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study
Eric Van Cutsem, Sabine Tejpar, Dirk Vanbeckevoort, et al.
Anti-Cancer Drugs
|
July 9, 2020
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study
Christoph Schulz, Volker Heinemann, Kathrin Heinrich, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 3, 2014
Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial
Thomas Thomaidis, Annett Maderer, Andrea Formentini, et al.
World Journal of Gastroenterology
|
July 31, 2007
Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy?
Daniel Drescher, Markus Moehler, Ines Gockel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 16, 2012
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)
Salah-Eddin Al-Batran, Claudia Pauligk, Nils Homann, et al.
The Lancet. Oncology
|
April 19, 2013
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Florian Lordick, Yoon-Koo Kang, Hyun-Cheol Chung, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 11, 2018
PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression
Bastian Dörsam, Nina Seiwert, Sebastian Foersch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 4, 2016
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives
Markus Moehler, Maike Delic, Katrin Goepfert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2025
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis
Giacomo Bregni, Bryan Leurquin, Peggy Giasafaki, et al.
International Journal of Cancer
|
October 15, 2013
High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer
Naohide Oue, Katsuhiro Anami, Aaron J Schetter, et al.
Page
of 22